Log in
Enquire now

List of Cidara Therapeutics patents

List of Cidara Therapeutics patents
List of ICERTIS, Inc. patents
List of Meijer patents
List of Elpida Memory patents
List of SBIR/STTR awards granted to Ideas Inc.
CEOs of hotel companies
Patents where
Current Assignee
Name
is
Cidara TherapeuticsCidara Therapeutics
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 10369188 Methods for preventing and treating pneumocystis infections

Patent 10369188 was granted and assigned to Cidara Therapeutics on August, 2019 by the United States Patent and Trademark Office.

Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10369188
August 6, 2019
‌
US Patent 11510992 Compositions and methods for the treatment of viral infections

Patent 11510992 was granted and assigned to Cidara Therapeutics on November, 2022 by the United States Patent and Trademark Office.

Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11510992
November 29, 2022
‌
US Patent 10016479 Dosing regimens for echinocandin class compounds

Patent 10016479 was granted and assigned to Cidara Therapeutics on July, 2018 by the United States Patent and Trademark Office.

Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10016479
July 10, 2018
‌
US Patent 9676821 Antifungal agents and uses thereof

Patent 9676821 was granted and assigned to Cidara Therapeutics on June, 2017 by the United States Patent and Trademark Office.

Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9676821
June 13, 2017
‌
US Patent 9526835 Dosing regimens for echinocandin class compounds

Patent 9526835 was granted and assigned to Cidara Therapeutics on December, 2016 by the United States Patent and Trademark Office.

Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9526835
December 27, 2016
‌
US Patent 9217014 Antifungal agents and uses thereof

Patent 9217014 was granted and assigned to Cidara Therapeutics on December, 2015 by the United States Patent and Trademark Office.

Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9217014
December 22, 2015
‌
US Patent 11524980 Synthesis of echinocandin antifungal agent

Patent 11524980 was granted and assigned to Cidara Therapeutics on December, 2022 by the United States Patent and Trademark Office.

Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11524980
December 13, 2022
‌
US Patent 10780144 Methods for preventing and treating pneumocystis infections

Patent 10780144 was granted and assigned to Cidara Therapeutics on September, 2020 by the United States Patent and Trademark Office.

Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10780144
September 22, 2020
‌
US Patent 10702573 Dosing regimens for echinocandin class compounds

Patent 10702573 was granted and assigned to Cidara Therapeutics on July, 2020 by the United States Patent and Trademark Office.

Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
10702573
July 7, 2020
‌
US Patent 11197909 Compositions and methods for the treatment of fungal infections

Patent 11197909 was granted and assigned to Cidara Therapeutics on December, 2021 by the United States Patent and Trademark Office.

Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11197909
December 14, 2021
‌
US Patent 11833213 Compositions and methods for the treatment of viral infections

Patent 11833213 was granted and assigned to Cidara Therapeutics on December, 2023 by the United States Patent and Trademark Office.

Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11833213
December 5, 2023
‌
US Patent 11712459 Dosing regimens for treatment of fungal infections

Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11712459
August 1, 2023
‌
US Patent 11654196 Dosing regimens for echinocandin class compounds

Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
Cidara Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
11654196
May 23, 2023
13 results
0 selected
13 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us